This inventor holds 3 USPTO granted patents. Top assignees: Ludwig Institute for Cancer Research Limited, Oxford University Innovation Ltd, The University of Birmingham. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 530 
2 out of 485 
2 out of 125 
Years Active: 2011-2012
Title: Gopal Reddy: Innovator in Cancer Research
Introduction
Gopal Reddy is a notable inventor based in Stony Brook, NY (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 3 patents, Reddy's work has the potential to impact therapeutic approaches in oncology.
Latest Patents
Among his latest patents are "Analogs of alpha galactosylceramide and uses thereof - Compounds of formula." This patent focuses on the development of compounds that could play a crucial role in cancer treatment. His research in this area demonstrates a commitment to advancing medical science and improving patient outcomes.
Career Highlights
Gopal Reddy has worked with prestigious organizations such as the Ludwig Institute for Cancer Research Limited and the University of Birmingham. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Reddy has collaborated with notable colleagues, including Vincenzo Cerundolo and Richard R. Schmidt. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Gopal Reddy's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile